17-11-4　ⓔ文献

  1. Rodeghiero F, Stasi R, et al: Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood, 2009; 113: 2386–2393.

  2. Kurata Y, Fujimura K, et al: Epidemiology of primary immune thrombocytopenia in children and adults in Japan: a population–based study and literature review. Int J Hematol, 2011; 93: 329–335.

  3. McMillan R, Wang L, et al: Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood, 2004; 103: 1364–1369.

  4. McMillan R, Tani P, et al: Platelet–associated and plasma anti–glycoprotein autoantibodies in chronic ITP. Blood, 1987; 70: 1040–1045.

  5. Tomiyama Y, Kosugi S: Autoantigenic epitopes on platelet glycoproteins. Int J Hematol, 2005; 81: 100–105.

  6. Kuwana M, Kurata Y, et al: Preliminary laboratory based diagnostic criteria for immune thrombocytopenic purpura: evaluation by multi–center prospective study. J Thromb Haemost, 2006; 4: 1936–1943.

  7. Kurata Y, Hayashi S, et al: Diagnostic value of tests for reticulated platelets, plasma glycocalicin, and thrombopoietin levels for discriminating between hyperdestructive and hypoplastic thrombocytopenia. Am J Clin Pathol, 2001; 115: 656–664.

  8. 冨山佳昭，清水一亘，他：免疫性血小板減少性紫斑病の免疫病態．臨床免疫・アレルギー科，2013; 59: 649–657.

  9. 柏木浩和，桑名正隆，他：成人特発性血小板減少性紫斑病治療の参照ガイド 2019改訂版．臨床血液，2019; 60: 877–896.